Obesity-Specific Association of Statin Use and Reduced Risk of Recurrence of Early Stage NSCLC
Introduction: Statins, used for their lipid-lowering activity, have anti-inflammatory and anticancer properties as well. We evaluated this potential benefit of statin use in patients with NSCLC. Methods: All 613 patients with pathologic stage 1 or 2 NSCLC who had lobectomy without neoadjuvant therap...
Guardado en:
Autores principales: | Santosh K. Patnaik, MD, PhD, Cara Petrucci, PhD, Joseph Barbi, PhD, Robert J. Seager, PhD, Sarabjot Pabla, PhD, Sai Yendamuri, MD |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/589bd2c2b95241a8bf3e7e8688a886b5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
MET Amplification and Efficacy of Nivolumab in Patients With NSCLC
por: Katsuhiro Yoshimura, MD, PhD, et al.
Publicado: (2021) -
Real-World Approach for Molecular Analysis of Acquired EGFR Tyrosine Kinase Inhibitor Resistance Mechanisms in NSCLC
por: Liesbeth M. Hondelink, MD, et al.
Publicado: (2021) -
Abemaciclib in Combination With Pembrolizumab for Stage IV KRAS-Mutant or Squamous NSCLC: A Phase 1b Study
por: Jean-Louis Pujol, MD, PhD, et al.
Publicado: (2021) -
Discrimination Between Primary Lung Cancer and Lung Metastases by Genomic Profiling
por: Rumi Higuchi, MD, et al.
Publicado: (2021) -
CADM1 and SPC25 Gene Mutations in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis
por: Aya Fukuizumi, MD, et al.
Publicado: (2021)